Alvotech (NASDAQ:ALVOW – Get Free Report) was the recipient of a large growth in short interest in February. As of February 27th, there was short interest totaling 1,444 shares, a growth of 20.8% from the February 12th total of 1,195 shares. Based on an average trading volume of 3,204 shares, the short-interest ratio is currently 0.5 days. Based on an average trading volume of 3,204 shares, the short-interest ratio is currently 0.5 days.
Alvotech Price Performance
NASDAQ:ALVOW opened at $0.33 on Monday. Alvotech has a 1 year low of $0.15 and a 1 year high of $3.00. The business has a fifty day moving average of $0.43 and a 200-day moving average of $0.85.
Alvotech Company Profile
Alvotech is a biopharmaceutical company specializing in the development and manufacturing of biosimilar medicines. Headquartered in Reykjavík, Iceland, the company focuses on creating high-quality, cost-effective alternatives to branded biologic therapies. Since its founding in 2013, Alvotech has built an integrated platform that spans research and development, clinical trials, regulatory submissions and commercial manufacturing.
Alvotech’s pipeline includes multiple biosimilar candidates addressing key therapeutic areas such as immunology, oncology and ophthalmology.
Featured Stories
- Five stocks we like better than Alvotech
- The $8,000 Gold Call Every Retirement Saver Needs to Read Right Now
- A personal warning from Martin Weiss (Please read)
- Elon Musk: This Could Turn $100 into $100,000
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- America’s gold reserves are priced at $42. The real price is $6,000+.
Receive News & Ratings for Alvotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alvotech and related companies with MarketBeat.com's FREE daily email newsletter.
